Form 8-K - Current report:
SEC Accession No. 0001641172-25-002577
Filing Date
2025-04-03
Accepted
2025-04-03 16:29:33
Documents
14
Period of Report
2025-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37863
  Complete submission text file 0001641172-25-002577.txt   209880

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ibo-20250403.xsd EX-101.SCH 3033
3 XBRL LABEL FILE ibo-20250403_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ibo-20250403_pre.xml EX-101.PRE 24178
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3493
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42212 | Film No.: 25809956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)